title: Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
abstract: Cholesteatoma of the middle ear is characterized by the presence of hyperproliferative keratinizing squamous epithelium in the middle ear cavity and destruction of adjacent bone. Interleukin 1 (IL-1) is an autocrine growth factor for normal keratinocytes and is capable of inducing bone degradation. The distribution of two molecular species of IL-1, IL-1 alpha and IL-1 beta, was investigated immunohistochemically in the hyperproliferative epithelium of cholesteatoma, in normal epidermis of the auditory canal and of the retroauricular region, and in nonkeratinizing tonsillar epithelium. In all squamous epithelia examined, IL-1 alpha and IL-1 beta were present in comparable amounts. The IL-1 content of cholesteatoma epithelium was clearly increased in relation to normal skin keratinocytes. All cellular layers of cholesteatoma epithelium stained strongly and uniformly for Il-1 alpha and IL-1 beta, whereas the keratin layer was negative for IL-1. No particularly strong reaction with basal cells was detected. In the connective tissue under the squamous epithelium of cholesteatoma, intensely positive cells were scattered between negative stromal cells. Our results suggest that IL-1 could be liberated from disintegrating keratinocytes and cells of the monocyte-macrophage lineage, stimulate the proliferation of the cholesteatoma epithelium in an autocrine manner, and contribute to the enhancement of bone destruction in the presence of cholesteatoma.
authors.affiliation: Ludwig-Maximilians-Universität, Klinikum Grosshadern, München, FRG.
authors.forename: V
authors.initials: V
authors.lastname: Schilling
authors.forename: B
authors.initials: B
authors.lastname: Negri
authors.forename: J
authors.initials: J
authors.lastname: Bujía
authors.forename: P
authors.initials: P
authors.lastname: Schulz
authors.forename: E
authors.initials: E
authors.lastname: Kastenbauer
mesh_terms: D002781:Cholesteatoma / Q000737:chemistry* / Q000209:etiology / Q000473:pathology; D004424:Ear Canal / Q000737:chemistry / Q000473:pathology; D004427:Ear Diseases / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D004431:Ear, External / Q000737:chemistry / Q000473:pathology; D004432:Ear, Middle / Q000737:chemistry* / Q000473:pathology; D004817:Epidermis / Q000737:chemistry / Q000473:pathology; D004848:Epithelium / Q000737:chemistry / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007375:Interleukin-1 / Q000032:analysis* / Q000502:physiology; D007633:Keratins; D014066:Palatine Tonsil / Q000737:chemistry / Q000473:pathology
chemical_list: D007375:Interleukin-1; D007633:Keratins